SOX5, a transcription factor involved in epithelial-mesenchymal transition (EMT) and metastasis, has been shown to promote tumor progression in other cancers (Chen X. et al., 2018; Hu et al., 2018). This evidence concerns the gene SOX5 and neoplasm.